Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Semler Scientific, Inc.
19.3% sales growth and 63.32% return on equity
Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States.
Semler Scientific, Inc.'s sales growth this year is anticipated to be 13.3% and 44.5% for next year.
Year-on-year quarterly revenue growth grew by 20.5%, now sitting on 35.68M for the twelve trailing months.
Semler Scientific, Inc.'s sales growth for the next quarter is 19.3%. The company's growth estimates for the ongoing quarter and the next is 16.2% and 30.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 63.32%.
Volatility
Semler Scientific, Inc.'s last day, last week, and last month's average volatility was a negative 2.18%, a negative 1.07%, and a positive 0.44%, respectively.
Semler Scientific, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 5.47%, 3.71%, and 4.99%, respectively.
Semler Scientific, Inc.'s Stock Yearly Top and Bottom Value
Semler Scientific, Inc.'s stock is valued at $85.75 at 10:22 EST, under its 52-week high of $95.00 and way higher than its 52-week low of $30.00.
Semler Scientific, Inc.'s Moving Average
Semler Scientific, Inc.'s value is above its 50-day moving average of $83.91 and way above its 200-day moving average of $61.83.2. Everest Re Group, Ltd.
13.3% sales growth and 7.2% return on equity
Everest Re Group, Ltd., through its subsidiaries, provides reinsurance and insurance products in the United States, Bermuda, and internationally.
Everest Re Group, Ltd.'s sales growth this year is expected to be 16.2% and 11.5% for next year.
Year-on-year quarterly revenue growth grew by 23.1%, now sitting on 8.96B for the twelve trailing months.
Everest Re Group, Ltd.'s sales growth for the next quarter is 13.3%. The company's growth estimates for the present quarter and the next is 7.8% and 64.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.2%.
Volatility
Everest Re Group, Ltd.'s last day, last week, and last month's average volatility was a negative 1.00%, a positive 0.44%, and a positive 0.09%, respectively.
Everest Re Group, Ltd.'s last day, last week, and last month's high and low average amplitude percentage was 2.48%, 2.93%, and 2.18%, respectively.
Everest Re Group, Ltd.'s Stock Yearly Top and Bottom Value
Everest Re Group, Ltd.'s stock is valued at $238.97 at 10:22 EST, way below its 52-week high of $294.31 and way above its 52-week low of $157.32.
Everest Re Group, Ltd.'s Moving Average
Everest Re Group, Ltd.'s value is higher than its 50-day moving average of $232.80 and above its 200-day moving average of $217.57.3. SciPlay Corporation
19.1% sales growth and 44.69% return on equity
SciPlay Corporation develops and publishes digital games on mobile and Web platforms worldwide.
SciPlay Corporation's sales growth this year is anticipated to be 24.6% and 1.3% for next year.
Year-on-year quarterly revenue growth grew by 29.9%, now sitting on 548M for the twelve trailing months.
SciPlay Corporation's sales growth for the next quarter is 19.1%. The company's growth estimates for the ongoing quarter and the next is 13% and 31.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 44.69%.
Volatility
SciPlay Corporation's last day, last week, and last month's average volatility was a negative 1.23%, a positive 0.99%, and a positive 0.71%, respectively.
SciPlay Corporation's last day, last week, and last month's high and low average amplitude percentage was 11.41%, 5.72%, and 5.32%, respectively.
SciPlay Corporation's Stock Yearly Top and Bottom Value
SciPlay Corporation's stock is valued at $17.04 at 10:22 EST, below its 52-week high of $18.75 and way above its 52-week low of $5.82.
SciPlay Corporation's Moving Average
SciPlay Corporation's worth is way higher than its 50-day moving average of $14.95 and way above its 200-day moving average of $14.65.4. Zoetis Inc.
5.7% sales growth and 52.89% return on equity
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally.
Zoetis Inc.'s sales growth this year is anticipated to be 5.2% and 7.9% for next year.
Year-on-year quarterly revenue growth grew by 12.8%, now sitting on 6.54B for the twelve trailing months.
Zoetis Inc.'s sales growth for the next quarter is 5.7%. The company's growth estimates for the ongoing quarter and the next is a negative 6.5% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 52.89%.
Volatility
Zoetis Inc.'s last day, last week, and last month's average volatility was 0.66%, 0.31%, and 0.27%, respectively.
Zoetis Inc.'s last day, last week, and last month's high and low average amplitude percentage was 1.91%, 2.31%, and 1.88%, respectively.
Zoetis Inc.'s Stock Yearly Top and Bottom Value
Zoetis Inc.'s stock is valued at $168.11 at 10:22 EST, below its 52-week high of $176.64 and way higher than its 52-week low of $90.14.
Zoetis Inc.'s Moving Average
Zoetis Inc.'s value is higher than its 50-day moving average of $161.69 and above its 200-day moving average of $157.57.5. TTEC Holdings, Inc.
9.2% sales growth and 24.4% return on equity
TTEC Holdings, Inc., a customer experience technology and services company, focuses on the design, implementation, and delivery of transformative customer experience for various brands.
TTEC Holdings, Inc.'s sales growth this year is anticipated to be 14.8% and 3.7% for next year.
Year-on-year quarterly revenue growth grew by 24.6%, now sitting on 1.84B for the twelve trailing months.
TTEC Holdings, Inc.'s sales growth for the next quarter is 9.2%. The company's growth estimates for the present quarter and the next is 9.2% and 3.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.4%.
Volatility
TTEC Holdings, Inc.'s last day, last week, and last month's average volatility was a negative 0.17%, a positive 1.18%, and a positive 0.25%, respectively.
TTEC Holdings, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 2.32%, 3.46%, and 3.33%, respectively.
TTEC Holdings, Inc.'s Stock Yearly Top and Bottom Value
TTEC Holdings, Inc.'s stock is valued at $0.00 at 10:22 EST, below its 52-week low of $26.28.
TTEC Holdings, Inc.'s Moving Average
TTEC Holdings, Inc.'s value is below its 50-day moving average of $73.15 and below its 200-day moving average of $59.19.6. Danaher Corporation
35.8% sales growth and 8.99% return on equity
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.
Danaher Corporation's sales growth this year is expected to be 22.7% and 15.8% for next year.
Year-on-year quarterly revenue growth grew by 34.4%, now sitting on 20.39B for the twelve trailing months.
Danaher Corporation's sales growth for the next quarter is 35.8%. The company's growth estimates for the ongoing quarter and the next is 43% and 54.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.99%.
Volatility
Danaher Corporation's last day, last week, and last month's average volatility was 1.42%, 1.67%, and 0.28%, respectively.
Danaher Corporation's last day, last week, and last month's high and low average amplitude percentage was 2.17%, 3.18%, and 2.14%, respectively.
Danaher Corporation's Stock Yearly Top and Bottom Value
Danaher Corporation's stock is valued at $239.71 at 10:22 EST, below its 52-week high of $248.32 and way higher than its 52-week low of $119.60.